StockData
Molecular Partners AG logo

Molecular Partners AG (MOLN) stock

MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 1/30
$2.67−0.19 (-6.82%)

Close on Nov 18, 2026Market cap $107.60MP/E –Yield –

Molecular Partners gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Molecular Partners

Molecular Partners has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Molecular Partners figures

See a number that looks wrong?